Stay up to date by getting 1 booster when you are eligible. People who are moderately or severely immunocompromisedįor most people, at least 2 months after the primary dose of J&J/Janssen COVID-19 vaccineįor people who are moderately or severely immunocompromised, at least 2 months after the additional dose of Pfizer-BioNTech or Moderna COVID-19 vaccineĪnyone who got a J&J/Janssen COVID-19 vaccine for both their primary dose and boosterĬDC recommends a booster of Pfizer-BioNTech vaccine:įor most children and teens, at least 5 months after the final dose in the primary seriesįor moderately or severely immunocompromised children and teens, at least 3 months after the final dose in the primary seriesĬhildren and teens who are moderately or severely immunocompromised can choose to get a 2nd booster of Pfizer-BioNTech COVID-19 vaccine at least 4 months after the 1st boosterġ. If you have completed your primary series-but are not yet eligible for a booster dose-you are also considered up to date. People in the following groups can choose to get a 2nd booster of either Pfizer-BioNTech or Moderna COVID-19 vaccine at least 4 months after the 1st booster:
#South carolina region x series#
Learn when you can get your 2nd booster below and what you should consider.ĬDC recommends a booster of either Pfizer-BioNTech or Moderna COVID-19 vaccine:įor most people, at least 5 months after the final dose in the primary seriesįor people who are moderately or severely immunocompromised, at least 3 months after the final dose in the primary series
People who got 2 doses (1 primary dose and 1 booster) of Johnson & Johnson’s Janssen vaccine People ages 12 years and older who are moderately or severely immunocompromised Learn when you can get your 1st booster below. You may get Johnson & Johnson’s Janssen COVID-19 vaccine in some situations.Įveryone ages 12 years and older can get 1 booster after completing their COVID-19 vaccine primary series. Pfizer-BioNTech or Moderna (COVID-19 mRNA vaccines) are preferred.
Three COVID-19 vaccines are authorized or approved for use in the United States to prevent COVID-19.
0 kommentar(er)
